Page last updated: 2024-08-24

milnacipran and desvenlafaxine succinate

milnacipran has been researched along with desvenlafaxine succinate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aziz, MT; Good, BL; Lowe, DK1
Bai, SJ; Huang, T; Lan, XH; Qin, B; Xie, P; Xu, Y1
Häuser, W; Klose, P; Üçeyler, N; Walitt, B; Welsch, P1

Reviews

3 review(s) available for milnacipran and desvenlafaxine succinate

ArticleYear
Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:5

    Topics: Antineoplastic Agents; Cyclohexanols; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Humans; Milnacipran; Neurotransmitter Uptake Inhibitors; Norepinephrine; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Serotonin; Thiophenes; Venlafaxine Hydrochloride

2014
Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2016, May-24, Volume: 49, Issue:6

    Topics: Adolescent; Antidepressive Agents; Child; Cyclopropanes; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Male; Milnacipran; Placebos; Randomized Controlled Trials as Topic; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2016
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    The Cochrane database of systematic reviews, 2018, 02-28, Volume: 2

    Topics: Adrenergic Uptake Inhibitors; Adult; Carnitine; Cyclopropanes; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Norepinephrine; Pregabalin; Quality of Life; Selective Serotonin Reuptake Inhibitors; Syndrome

2018